DAFNA Capital Management’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
Other funds holding AQST
BCM
DAFNA Capital Management's AQST Position: Q3 2026 in Review
DAFNA Capital Management reduced its Aquestive Therapeutics (AQST) stake by 0.77% in Q3 2026, selling an estimated $22.2K and leaving 640,915 shares worth $2.97M. The position accounts for 0.63% of the portfolio, ranked #37.
DAFNA Capital Management first reported a position in AQST in Q1 2024 and has held it in 11 quarters since. 190 funds tracked by Wall St. Rank hold AQST as of Q3 2026.
- DAFNA Capital Management held 640,915 shares of Aquestive Therapeutics worth $2.97M as of Q3 2026.
- DAFNA Capital Management sold 5,000 Aquestive Therapeutics shares in Q3 2026, an estimated $22.2K.
- Aquestive Therapeutics made up 0.63% of DAFNA Capital Management's portfolio in Q3 2026, its #37 holding.
- DAFNA Capital Management first reported a position in Aquestive Therapeutics in Q1 2024 and has held it in 11 quarters since.
- 190 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q3 2026.
Based on DAFNA Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.